최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Journal of cardiovascular pharmacology and therapeutics, v.15 no.2, 2010년, pp.167 - 174
Her, Ae-Young (Cardiology Division, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea) , Kim, Jong-Youn (Cardiology Division, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea) , Kang, Seok-Min (Cardiology Division, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea) , Choi, Donghoon (Cardiology Division, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea) , Jang, Yangsoo (Cardiology Division, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea) , Chung, Namsik (Cardiology Division, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea) , Manabe, Ichiro (Department of Cardiovascular Medicine and Nano-Bioengineering Education Program, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan) , Lee, Sang-Hak (Cardiology Division, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea,)
The aim of this study was to compare the effects of 3 different statin regimens that have equivalent low-density lipoprotein cholesterol (LDL-C) lowering efficacy on the apolipoprotein B/A1 ratio and glucose metabolism. After a 4-week dietary lead-in, 90 hypercholeserolemic patients were randomly a...
Sager, Philip T., Capece, Rachel, Lipka, Leslie, Strony, John, Yang, Bo, Suresh, Ramachandran, Mitchel, Yale, Veltri, Enrico. Effects of ezetimibe coadministered with simvastatin on C-reactive protein in a large cohort of hypercholesterolemic patients. Atherosclerosis, vol.179, no.2, 361-367.
Rizzo, Manfredi, Berneis, Kaspar. The Clinical Relevance of Low-Density-Lipoproteins Size Modulation by Statins. Cardiovascular drugs and therapy, vol.20, no.3, 205-217.
Sasaki, Jun, Iwashita, Mikio, Kono, Suminori. Statins: Beneficial or Adverse for Glucose Metabolism. Journal of atherosclerosis and thrombosis, vol.13, no.3, 123-129.
WOLFFENBUTTEL, B. H. R., FRANKEN, A. A. M., VINCENT, H. H.. Cholesterol-lowering effects of rosuvastatin compared with atorvastatin in patients with type 2 diabetes – CORALL study. Journal of internal medicine, vol.257, no.6, 531-539.
Freeman, Dilys J., Norrie, John, Sattar, Naveed, Neely, R. Dermot G., Cobbe, Stuart M., Ford, Ian, Isles, Christopher, Lorimer, A. Ross, Macfarlane, Peter W., McKillop, James H., Packard, Christopher J., Shepherd, James, Gaw, Allan. Pravastatin and the Development of Diabetes Mellitus : Evidence for a Protective Treatment Effect in the West of Scotland Coronary Prevention Study. Circulation, vol.103, no.3, 357-362.
Ridker, Paul M, Danielson, Eleanor, Fonseca, Francisco A.H., Genest, Jacques, Gotto Jr., Antonio M., Kastelein, John J.P., Koenig, Wolfgang, Libby, Peter, Lorenzatti, Alberto J., MacFadyen, Jean G., Nordestgaard, Børge G., Shepherd, James, Willerson, James T., Glynn, Robert J.. Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein. The New England journal of medicine, vol.359, no.21, 2195-2207.
Walldius, Göran, Jungner, Ingmar, Holme, Ingar, Aastveit, Are H, Kolar, Werner, Steiner, Eugen. High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study. The Lancet, vol.358, no.9298, 2026-2033.
Benn, Marianne, Nordestgaard, Børge G., Jensen, Gorm Boje, Tybjærg-Hansen, Anne. Improving Prediction of Ischemic Cardiovascular Disease in the General Population Using Apolipoprotein B : The Copenhagen City Heart Study. Arteriosclerosis, thrombosis, and vascular biology, vol.27, no.3, 661-670.
Feldman, Theodore, Koren, Michael, Insull Jr., William, McKenney Jr., James, Schrott Jr., Helmut, Lewin Jr., Andrew, Shah Jr., Sukrut, Sidisin Jr., Michelle, Cho Jr., Meehyung, Kush Jr., Debra, Mitchel Jr., Yale. Treatment of High-Risk patients with ezetimibe plus simvastatin Co-Administration versus simvastatin alone to attain National Cholesterol Education Program Adult Treatment Panel III Low-Density lipoprotein cholesterol goals. The American journal of cardiology, vol.93, no.12, 1481-1486.
Ballantyne, Christie M, Blazing, Michael A, King, Thomas R, Brady, William E, Palmisano, Joanne. Efficacy and safety of ezetimibe co-administered with simvastatin compared with atorvastatin in adults with hypercholesterolemia. The American journal of cardiology, vol.93, no.12, 1487-1494.
Stein, Evan, Stender, Steen, Mata, Pedro, Sager, Philip, Ponsonnet, Damien, Melani, Lorenzo, Lipka, Leslie, Suresh, Ramachandran, MacCubbin, Darbie, Veltri, Enrico. Achieving lipoprotein goals in patients at high risk with severe hypercholesterolemia: Efficacy and safety of ezetimibe co-administered with atorvastatin. The American heart journal, vol.148, no.3, 447-455.
Tremblay, André J., Lamarche, Benoît, Cohn, Jeffrey S., Hogue, Jean-Charles, Couture, Patrick. Effect of Ezetimibe on the In Vivo Kinetics of ApoB-48 and ApoB-100 in Men With Primary Hypercholesterolemia. Arteriosclerosis, thrombosis, and vascular biology, vol.26, no.5, 1101-1106.
Kalogirou, Mihalis, Tsimihodimos, Vasilis, Gazi, Irene, Filippatos, Theodosios, Saougos, Vasilis, Tselepis, Alexandros D., Mikhailidis, Dimitri P., Elisaf, Moses. Effect of ezetimibe monotherapy on the concentration of lipoprotein subfractions in patients with primary dyslipidaemia. Current medical research and opinion : CMRO, vol.23, no.5, 1169-1176.
Denke, Margo, Pearson, Thomas, McBride, Patrick, Gazzara, Russell A, Brady, William E, Tershakovec, Andrew M. Ezetimibe added to ongoing statin therapy improves LDL-C goal attainment and lipid profile in patients with diabetes or metabolic syndrome. Diabetes & vascular disease research : official journal of the International Society of Diabetes and Vascular Disease, vol.3, no.2, 93-102.
Piorkowski, M., Fischer, S., Stellbaum, C., Jaster, M., Martus, P., Morguet, A.J., Schultheiss, H.P., Rauch, U.. Treatment With Ezetimibe Plus Low-Dose Atorvastatin Compared With Higher-Dose Atorvastatin Alone. Journal of the American College of Cardiology, vol.49, no.10, 1035-1042.
Liu, Ping-Yen, Liu, Yen-Wen, Lin, Li-Jen, Chen, Jyh-Hong, Liao, James K.. Evidence for Statin Pleiotropy in Humans : Differential Effects of Statins and Ezetimibe on Rho-Associated Coiled-Coil Containing Protein Kinase Activity, Endothelial Function, and Inflammation. Circulation, vol.119, no.1, 131-138.
Deedwania, Prakash C., Hunninghake, Donald B., Bays, Harold E., Jones, Peter H., Cain, Valerie A., Blasetto, James W.. Effects of rosuvastatin, atorvastatin, simvastatin, and pravastatin on atherogenic dyslipidemia in patients with characteristics of the metabolic syndrome. The American journal of cardiology, vol.95, no.3, 360-366.
Milionis, Haralampos J., Rizos, Evangelos, Kostapanos, Michael, Filippatos, Theodosios D., Gazi, Irene F., Ganotakis, Emmanuel S., Goudevenos, John, Mikhailidis, Dimitri P., Elisaf, Moses S.. Treating to target patients with primary hyperlipidaemia:comparison of the effects of ATOrvastatin and ROSuvastatin (the ATOROS study). Current medical research and opinion : CMRO, vol.22, no.6, 1123-1131.
Am Heart J. Schwarz GG e4 148 1 2004 10.1016/S0002-8703(04)00376-X
Freeman, Dilys J., Norrie, John, Sattar, Naveed, Neely, R. Dermot G., Cobbe, Stuart M., Ford, Ian, Isles, Christopher, Lorimer, A. Ross, Macfarlane, Peter W., McKillop, James H., Packard, Christopher J., Shepherd, James, Gaw, Allan. Pravastatin and the Development of Diabetes Mellitus : Evidence for a Protective Treatment Effect in the West of Scotland Coronary Prevention Study. Circulation, vol.103, no.3, 357-362.
Lancet Hear Protection Study Collaborative Group. 360 9326 2002
Lancet Sever PS 1149 361 9364 2003 10.1016/S0140-6736(03)12948-0
Cannon, Christopher P., Braunwald, Eugene, McCabe, Carolyn H., Rader, Daniel J., Rouleau, Jean L., Belder, Rene, Joyal, Steven V., Hill, Karen A., Pfeffer, Marc A., Skene, Allan M.. Intensive versus Moderate Lipid Lowering with Statins after Acute Coronary Syndromes. The New England journal of medicine, vol.350, no.15, 1495-1504.
Huptas, Sebastian, Geiss, Hans-Christian, Otto, Carsten, Parhofer, Klaus Georg. Effect of Atorvastatin (10 mg/day) on Glucose Metabolism in Patients With the Metabolic Syndrome. The American journal of cardiology, vol.98, no.1, 66-69.
Tanaka, Akira, Yamada, Nobuhiro, Saito, Yasushi, Kawakami, Masanobu, Ohashi, Yasuo, Akanuma, Yasuo. A double-blind trial on the effects of atorvastatin on glycemic control in Japanese diabetic patients with hypercholesterolemia. Clinica chimica acta, vol.312, no.1, 41-47.
Takano, Tatsuro, Yamakawa, Tadashi, Takahashi, Mayumi, Kimura, Mari, Okamura, Atsushi. Influences of Statins on Glucose Tolerance in Patients with Type 2 Diabetes Mellitus. Journal of atherosclerosis and thrombosis, vol.13, no.2, 95-100.
Clin Ther Sasaki J. 1089 30 6 2008 10.1016/j.clinthera.2008.05.017
Yada, Toshihiko, Nakata, Masanori, Shiraishi, Tomoko, Kakei, Masafumi. Inhibition by simvastatin, but not pravastatin, of glucose‐induced cytosolic Ca2+ signalling and insulin secretion due to blockade of L‐type Ca2+ channels in rat islet β‐cells. British journal of pharmacology : BJP, vol.126, no.5, 1205-1213.
Ishikawa, Mayumi, Okajima, Fuminori, Inoue, Noriyuki, Motomura, Kaori, Kato, Toyonori, Takahashi, Akimitsu, Oikawa, Shinichi, Yamada, Nobuhiro, Shimano, Hitoshi. Distinct Effects of Pravastatin, Atorvastatin, and Simvastatin on Insulin Secretion from a β-cell Line, MIN6 Cells. Journal of atherosclerosis and thrombosis, vol.13, no.6, 329-335.
Nakata, M., Nagasaka, S., Kusaka, I., Matsuoka, H., Ishibashi, S., Yada, T.. Effects of statins on the adipocyte maturation and expression of glucose transporter 4 (SLC2A4): implications in glycaemic control. Diabetologia, vol.49, no.8, 1881-1892.
Dagli, Necati, Yavuzkir, Mustafa, Karaca, Ilgin. The Effects of High Dose Pravastatin and Low Dose Pravastatin and Ezetimibe Combination Therapy on Lipid, Glucose Metabolism and Inflammation. Inflammation, vol.30, no.6, 230-235.
Naples, M., Federico, L.M., Xu, E., Nelken, J., Adeli, K.. Effect of rosuvastatin on insulin sensitivity in an animal model of insulin resistance: Evidence for statin-induced hepatic insulin sensitization. Atherosclerosis, vol.198, no.1, 94-103.
Kostapanos, M. S., Milionis, H. J., Agouridis, A.-D., Rizos, C. V., Elisaf, M. S.. Rosuvastatin treatment is associated with an increase in insulin resistance in hyperlipidaemic patients with impaired fasting glucose. International journal of clinical practice, vol.63, no.9, 1308-1313.
Clearfield, Michael B, Amerena, John, Bassand, Jean-Pierre, García, Hugo R Hernández, Miller, Sam S, Sosef, Froukje FM, Palmer, Michael K, Bryzinski, Brian S. Comparison of the efficacy and safety of rosuvastatin 10 mg and atorvastatin 20 mg in high-risk patients with hypercholesterolemia – Prospective study to evaluate the Use of Low doses of the Statins Atorvastatin and Rosuvastatin (PULSAR). Trials, vol.7, 35-35.
Am J Manag Care Baruch L. 637 14 10 2008
Kosoglou, Teddy, Statkevich, Paul, Meyer, Ingo, Cutler, David L., Musiol, Bernhard, Yang, Bo, Zhu, Yali, Maxwell, Stephen E., Veltri, Enrico P.. Effects of ezetimibe on the pharmacodynamics and pharmacokinetics of lovastatin. Current medical research and opinion : CMRO, vol.20, no.6, 955-965.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.